about
Quantification of infarct size and myocardium at risk: evaluation of different techniques and its implications.The effect of reducing spatial resolution by in-plane partial volume averaging on peak velocity measurements in phase contrast magnetic resonance angiographyInfarct size reduction in acute myocardial infarction.Measurement of myocardium at risk with cardiovascular MR: comparison of techniques for edema imaging.Formal consensus to identify clinically important changes in management resulting from the use of cardiovascular magnetic resonance (CMR) in patients who activate the primary percutaneous coronary intervention (PPCI) pathway.Accuracy of large vessel flow evaluation performed by technologists in patients with congenital heart disease using cardiac MRI.T2 mapping vs T2 weighted imaging in the detection of myocardial oedema.Inter- and intra-study reproducibility of LV volume analysis performed by technologists.Incremental diagnostic role of cardiac MRI in young-middle aged patients with high-grade atrio-ventricular block.Early gadolinium enhancement for the detection of myocardial oedema (EGE vs T2-STIR vs ACUT2E): a new method to assess the area at risk?Prevalance of non-cardiac pathology on cardiovascular magnetic resonance studies.Stress CMR as a gatekeeper to complete revascularisation in STEMI patients with moderate-severe bystander disease at primary percutaneous coronary intervention.The impact of infarct size on regional and global left ventricular systolic function: a cardiac magnetic resonance imaging study.Optimising the imaging plane for right ventricular magnetic resonance volume analysis in adult patients referred for assessment of right ventricular structure and function.Impact of gender differences on myocardial salvage and post-ischaemic left ventricular remodelling after primary coronary angioplasty: new insights from cardiovascular magnetic resonance.A Novel Cause of Acute Coronary Syndrome Due to Dynamic Extrinsic Coronary Artery Compression by a Rib Exostosis: Multimodality Imaging Diagnosis.Remote myocardium is also affected in acute myocardial infarction: evidence from advanced CMR relaxometry.Cardiovascular magnetic resonance imaging in patients with MR-conditional devices: a UK tertiary centre experience on image quality and change in patients management.Infarct size by SS-SSFP vs. IR-GRE: influence of imaging time after contrast administration and infarct age, and implications for clinical trials.The diagnostic role of cardiovascular magnetic resonance imaging in patients surviving non traumatic out of hospital cardiac arrest.The association between microvascular obstruction by CMR and the index of microcirculatory resistance assessed invasively.New "gold standard" for assessing myocardial oedema in STEMI?Evaluation of 7 techniques for the quantification of myocardial oedema in STEMICMR endpoints for clinical trials: impact of operator experience on the accuracy of image analysisMicrovascular dysfunction determines infarct characteristics in patients with reperfused ST-segment elevation myocardial infarction: The MICROcirculation in Acute Myocardial Infarction (MICRO-AMI) studyHigh throughput clinical CMR service: role of technologists in LV volume analysisTiming of post contrast T1 values affects the extracellular volume fraction in ST segment elevation myocardial infarctionT2 values of the acutely infarcted myocardium following primary PCI: the relationship with infarct characteristics and gadolinium extracellular volume of distributionMagnetic resonance imaging–based management of silent cardiac ruptureIsolated Anomalous Right Coronary Artery From the Pulmonary Artery in AdulthoodQuadruple valve replacement for valve destruction in carcinoid heart disease
P50
Q35718217-FFD2ECD7-314B-4706-AC21-BD161833784EQ37458893-AA30F002-B925-4EB4-B17F-D9531A8CDEBBQ38211842-D2EF58CE-0A6C-4B28-ADF4-7CAAAA4CD7F7Q38432740-041C86CB-FE77-4CE2-9B64-96901565E469Q39395271-761A92F9-5FA2-49F0-8F61-0BF8660C5B4DQ46071095-55B37304-7085-4F81-858C-F7E309985158Q46209750-92444B7A-CB84-4418-B421-AA8D2D792CF0Q46533353-9B6159A8-A1DA-464F-B008-543806931107Q46606462-63F2EE78-F5F1-4E56-BA9D-AFA2DC41C306Q46692571-5C842023-523F-4804-9610-2012736D948EQ46697377-069DC0FE-5783-4D28-BECF-8FC1E3119C9CQ47165563-A4E9DB31-AB62-45EE-B170-445C62901B67Q47394429-193FEC51-CAC4-4B3D-9B9A-5798287829E0Q51031353-64F0B014-9B3A-4905-9DCC-C71CF68BEDF1Q51344152-E742BB0D-E324-4611-9894-485F636B7295Q51605725-EAB852DC-7F1C-409E-9FDB-CC0A18E27BCDQ54969993-D7A9252D-BA46-4CF7-86D1-2FE0472ACA9CQ55066541-CE4B7D4D-30C8-4BE2-843D-4AE087CA5430Q55527421-3369C6D6-5191-4CFD-9558-C0087D032BB5Q55531312-D85D710E-5CA7-47BA-B64C-3BC2026B388EQ55531475-300DFB01-8138-4499-B174-DC65610F312EQ55710430-F9877E56-0B0E-45A1-9486-F7BE47B27C69Q57831054-20FBB3B1-00AE-4067-BE5F-68C2FEC127A0Q57831083-D687FC1D-E71F-49A1-BDA7-70A898D468D9Q59129683-17D5EE6C-0BDA-4465-ACDA-3AD5D1A0FB1DQ59291588-C6D5362C-D365-4984-B80A-49EA17066596Q59410440-E467DE6B-9106-48D5-BD1E-53313D53E4B8Q59410474-E9A25E55-87F5-4E83-A516-A2C1337D3F10Q62075655-2B81C826-F429-43FA-BE5B-4E89E7D7B90CQ63476471-8557766E-729C-4CED-A089-7A89BC3F9029Q63476523-B6D6812A-4D67-413B-80B8-0F94A43850EB
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Elisa McAlindon
@ast
Elisa McAlindon
@en
Elisa McAlindon
@es
Elisa McAlindon
@fr
Elisa McAlindon
@nl
Elisa McAlindon
@sl
type
label
Elisa McAlindon
@ast
Elisa McAlindon
@en
Elisa McAlindon
@es
Elisa McAlindon
@fr
Elisa McAlindon
@nl
Elisa McAlindon
@sl
prefLabel
Elisa McAlindon
@ast
Elisa McAlindon
@en
Elisa McAlindon
@es
Elisa McAlindon
@fr
Elisa McAlindon
@nl
Elisa McAlindon
@sl
P106
P21
P31
P496
0000-0003-0743-3661